rs56318008
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000441048.1(WNT4):c.-271G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.136 in 152,258 control chromosomes in the GnomAD database, including 2,203 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 2202 hom., cov: 32)
Exomes 𝑓: 0.21 ( 1 hom. )
Consequence
WNT4
ENST00000441048.1 5_prime_UTR
ENST00000441048.1 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0380
Publications
27 publications found
Genes affected
WNT4 (HGNC:12783): (Wnt family member 4) The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family, and is the first signaling molecule shown to influence the sex-determination cascade. It encodes a protein which shows 98% amino acid identity to the Wnt4 protein of mouse and rat. This gene and a nuclear receptor known to antagonize the testis-determining factor play a concerted role in both the control of female development and the prevention of testes formation. This gene and another two family members, WNT2 and WNT7B, may be associated with abnormal proliferation in breast tissue. Mutations in this gene can result in Rokitansky-Kuster-Hauser syndrome and in SERKAL syndrome. [provided by RefSeq, Jul 2008]
WNT4 Gene-Disease associations (from GenCC):
- mullerian aplasia and hyperandrogenismInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
- SERKAL syndromeInheritance: AR, Unknown Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.492 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| WNT4 | ENST00000441048.1 | c.-271G>A | 5_prime_UTR_variant | Exon 1 of 3 | 5 | ENSP00000388925.1 | ||||
| ENSG00000285873 | ENST00000648968.1 | n.55+1010C>T | intron_variant | Intron 1 of 4 | ||||||
| ENSG00000285873 | ENST00000808862.1 | n.36+1010C>T | intron_variant | Intron 1 of 4 |
Frequencies
GnomAD3 genomes AF: 0.136 AC: 20729AN: 152082Hom.: 2200 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
20729
AN:
152082
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.207 AC: 12AN: 58Hom.: 1 Cov.: 0 AF XY: 0.217 AC XY: 10AN XY: 46 show subpopulations
GnomAD4 exome
AF:
AC:
12
AN:
58
Hom.:
Cov.:
0
AF XY:
AC XY:
10
AN XY:
46
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2
East Asian (EAS)
AF:
AC:
1
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
3
AN:
16
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
8
AN:
30
Other (OTH)
AF:
AC:
0
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.136 AC: 20738AN: 152200Hom.: 2202 Cov.: 32 AF XY: 0.144 AC XY: 10687AN XY: 74408 show subpopulations
GnomAD4 genome
AF:
AC:
20738
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
10687
AN XY:
74408
show subpopulations
African (AFR)
AF:
AC:
1312
AN:
41548
American (AMR)
AF:
AC:
3700
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
242
AN:
3468
East Asian (EAS)
AF:
AC:
2621
AN:
5162
South Asian (SAS)
AF:
AC:
938
AN:
4812
European-Finnish (FIN)
AF:
AC:
1733
AN:
10598
Middle Eastern (MID)
AF:
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9705
AN:
67992
Other (OTH)
AF:
AC:
264
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
874
1748
2622
3496
4370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1030
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.